Anti-Influenza A Virus Hemagglutinin H5 HA Therapeutic Antibody scFv Fragment (Yu22-6)

This product is a recombinant humanized anti-influenza A virus hemagglutinin H5 monoclonal antibody. Yu22-6 specifically binds to HA and can be potentially usd in the treatment of influenza virus infection.
Supplier Creative Biolabs
Product # MRO-258LC-S(P)
Pricing Inquiry
Type Humanized antibody
Host Human
Target HA
Feedback